We are live on
!
Find out more
Calamos Advisors Portfolio holdings
AUM
$28.2B
1-Year Est. Return
21.78%
This Fund
S&P 500
This Quarter
Est. Return
+17.1%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$14.1B
AUM Growth
+$1.4B
(+11%)
Cap. Flow
-$4.28B
Cap. Flow
% of AUM
-30.25%
Top 10 Holdings %
Top 10 Hldgs %
20.4%
Holding
803
New
108
Increased
91
Reduced
295
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BSX.PRA
Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
|
+$61M |
| 2 |
RTX Corp
RTX
|
+$38.2M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$15.5M |
| 4 |
Delta Air Lines
DAL
|
+$14.5M |
| 5 |
SWT
Stanley Black & Decker, Inc.
SWT
|
+$13.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$578M |
| 2 |
AGN
Allergan plc
AGN
|
+$67M |
| 3 |
BDXA
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6
BDXA
|
+$51.1M |
| 4 |
Alibaba
BABA
|
+$46.8M |
| 5 |
lululemon athletica
LULU
|
+$42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.91% |
| 2 | Healthcare | 8.15% |
| 3 | Consumer Discretionary | 7.49% |
| 4 | Financials | 7.2% |
| 5 | Communication Services | 5.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Wells Fargo
WFC
$264B
| $35.2M | 0.25% |
1,374,299
-171,323
| -11% | -$4.69M |
|
77
Global Payments
GPN
$23B
| $35.2M | 0.25% |
207,397
-43,726
| -17% | -$7.28M |
|
78
Accenture
ACN
$94.3B
| $34.9M | 0.25% |
162,657
-25,012
| -13% | -$4.73M |
|
|
79
lululemon athletica
LULU
$13.4B
| $34.8M | 0.25% |
111,602
-164,295
| -60% | -$42M |
|
80
Abbott
ABT
$182B
| $34.1M | 0.24% |
373,124
-14,754
| -4% | -$1.33M |
|
81
Thermo Fisher Scientific
TMO
$208B
| $34.1M | 0.24% |
94,019
-2,962
| -3% | -$993K |
|
82
Gilead Sciences
GILD
$162B
| $32.8M | 0.23% |
425,921
-116,560
| -21% | -$8.93M |
|
83
Northrop Grumman
NOC
$77.8B
| $32.3M | 0.23% |
105,169
+11,814
| +13% | +$3.87M |
|
84
Lockheed Martin
LMT
$134B
| $31.7M | 0.22% |
86,990
-19,236
| -18% | -$7.27M |
|
85
Twilio
TWLO
$29.5B
| $31.3M | 0.22% |
142,712
-148,614
| -51% | -$23.9M |
|
|
SRE.PRB
86
DELISTED
Sempra 6.75% Mandatory Convertible Preferred Stock, Series B
SRE.PRB
| $31.3M | 0.22% |
318,407
-265
| -0.1% | -$26.8K |
|
87
Humana
HUM
$45.8B
| $31M | 0.22% |
80,012
-40,863
| -34% | -$15.3M |
|
88
TJX Companies
TJX
$173B
| $30.7M | 0.22% |
607,145
+186,761
| +44% | +$9.38M |
|
89
Lyft
LYFT
$5.73B
| $30.3M | 0.21% |
916,460
-177,478
| -16% | -$5.61M |
|
90
Workday
WDAY
$36.4B
| $30M | 0.21% |
160,271
+76,431
| +91% | +$12.4M |
|
|
DTP
91
DELISTED
DTE Energy Company 2019 Corporate Units
DTP
| $29.5M | 0.21% |
696,129
+57,700
| +9% | +$2.39M |
|
|
CFXA
92
DELISTED
Colfax Corporation 5.75% Tangible Equity Units
CFXA
| $29.3M | 0.21% |
240,000
| – | – |
|
93
Costco
COST
$422B
| $29.1M | 0.21% |
96,092
-11,507
| -11% | -$3.5M |
|
94
Mondelez International
MDLZ
$77.9B
| $29M | 0.21% |
567,277
-20,377
| -3% | -$1.05M |
|
95
AbbVie
ABBV
$454B
| $28.7M | 0.2% |
292,808
+34,714
| +13% | +$3.06M |
|
96
Constellation Brands
STZ
$22.2B
| $28.2M | 0.2% |
161,404
-21,891
| -12% | -$3.65M |
|
97
American International
AIG
$42B
| $27.9M | 0.2% |
893,613
-20,852
| -2% | -$585K |
|
98
Morgan Stanley
MS
$337B
| $27.8M | 0.2% |
575,128
+45,576
| +9% | +$1.91M |
|
99
TSMC
TSM
$2.07T
| $27.6M | 0.2% |
485,969
+34,895
| +8% | +$1.84M |
|
100
Advanced Micro Devices
AMD
$807B
| $27.2M | 0.19% |
516,657
-9,652
| -2% | -$512K |
|
Similar funds
PCH
N
TWC
FDCDDQ
NA
Calamos Advisors's Q2 2020 Portfolio in Review
As of Q2 2020, Calamos Advisors held 803 positions worth $14.1B, up 11% from $12.7B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Calamos Advisors withdrew a net $4.28B in Q2 2020, closing 98 positions and reducing 295 holdings. Its most notable exit was Allergan plc, an estimated $67M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Calamos Advisors opened a new position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A worth $59.7M.
- Calamos Advisors's largest Q2 2020 buy was Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A: 569,916 shares worth $59.7M.
- Calamos Advisors added most to RTX Corp in Q2 2020, an estimated $38.2M increase.
- Calamos Advisors's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $578M.
- Calamos Advisors fully exited Allergan plc in Q2 2020, selling an estimated $67M.
- Calamos Advisors's ten largest holdings make up 20% of its $14.1B portfolio in Q2 2020.
- Calamos Advisors opened 108 new positions and closed 98 in Q2 2020.
- Calamos Advisors's portfolio value rose 11% quarter-over-quarter to $14.1B.
Based on Calamos Advisors's 13F filing for Q2 2020, filed 27 Jul 2020.